BACE-1 inhibitors part 3: Identification of hydroxy ethylamines (HEAs) with nanomolar potency in cellsPaul Beswick, Gareth Wayne, Alan Naylor et al.|Bioorganic & Medicinal Chemistry Letters|2008Cited by 58
BACE-1 inhibitors part 2: Identification of hydroxy ethylamines (HEAs) with reduced peptidic characterBrian Clarke, Gareth Wayne, Emmanuel H. Demont et al.|Bioorganic & Medicinal Chemistry Letters|2008Cited by 57
BACE-1 inhibitors Part 1: Identification of novel hydroxy ethylamines (HEAs)Brian Clarke, Gareth Wayne, Emmanuel H. Demont et al.|Bioorganic & Medicinal Chemistry Letters|2008Cited by 47
Human BACE-1 in complex with N-((1S,2R)-3-(cyclohexylamino)-2-hydroxy- 1-(phenylmethyl)propyl)-3-(ethylamino)-5-(2-oxo-1-pyrrolidinyl) benzamideB. Clarke, G. Wayne, Emmanuel H. Demont et al.|Unknown|2007Cited by 0
Human BACE-1 in complex with N-((1S,2R)-1-benzyl-2-hydroxy-3-((1,1,5- trimethylhexyl)amino)propyl)-3-(ethylamino)-5-(2-oxopyrrolidin-1-yl) benzamideB. Clarke, G. Wayne, Emmanuel H. Demont et al.|Unknown|2007Cited by 0